Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma. - Wikidata - awgldk - TriplyDB

Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.

Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.

http://www.wikidata.org/entity/Q37109698

about

The organic ester O,O’-diethyl-(S,S)-ethylenediamine-N,N’-di-2-(3-cyclohexyl)propanoate dihydrochloride attenuates murine breast cancer growth and metastasis.The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine The Role of IL-33/ST2 Pathway in Tumorigenesis

P2860

Q55378234-306F1B7C-32AA-4FEA-9D3F-5FB1ECE971EE Q58707724-09113345-02E3-4792-A81C-0D91EEA87DE7 Q58756972-3630E35F-4986-47E0-8228-AE6409D36955

P2860

Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.

http://www.wikidata.org/entity/Q37109698

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 February 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.

@en

Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.

@nl

type

label

Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.

@en

Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.

@nl

prefLabel

Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.

@en

Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.

@nl

P1433

Q37109698-A82A8101-B4B5-45F5-AF61-9F24565F07EC

P1476

Q37109698-F2F65379-1ED8-4D0E-81D1-12CB7F7363B4

P2093

Q37109698-2206606D-DB6E-47A4-9036-B0BD37D9B804

Q37109698-63FC2392-8E41-4941-BD02-5887DBD12DB8

Q37109698-7AB9C630-9D48-4E6F-8292-A7CC6B81CA09

Q37109698-9A1D0867-0BE3-4020-AAAB-B2685AB4F138

Q37109698-B569A224-6FAD-4EB3-8D78-F6CA20F434A3

P2860

Q37109698-044C19BF-6618-4EA5-8CDE-38AA283E81B8

Q37109698-0490F8A8-9A50-4755-8F60-00E326849C3F

Q37109698-059D36C1-DAA4-4350-89EB-6672011C700B

Q37109698-07AA88C9-90ED-4405-A842-9E73D3ACA2B4

Q37109698-27925916-A941-4696-BCF5-06053FB31A30

Q37109698-2DB17C16-183C-4E6B-93DC-5243A1B2B1FC

Q37109698-2ED8E4A7-7E3A-4942-9E40-CBE327CA2561

Q37109698-2FFF5504-CA40-44D2-AE84-18AD64503F0D

Q37109698-33523F47-CE8B-48C6-BC80-044AEE1A8E3A

Q37109698-33B4D2DD-5E0F-4E87-84FD-6614AA71FE58

P304

Q37109698-36EF7986-CEF5-43A5-8007-4CD52898BEA3

P31

Q37109698-802483D8-1461-4BBE-9655-743E3585A5EB

P356

Q37109698-C6FAB0B2-6E80-4052-AD3A-ACD001781E04

P407

Q37109698-FD9453B4-1DD6-4BA1-BAD4-9ED824244CA0

P433

Q37109698-77C2C8C5-42F1-4264-8DA6-5B670CA7F58E

P478

Q37109698-FDB8B235-54B0-4FE4-8FF7-D581F554AEEC

P50

Q37109698-37113C76-1CDC-4E47-A9DE-9CF3CE2402F7

Q37109698-BF7D14CE-E549-446F-B782-8CE8FAD78E22

P577

Q37109698-215F9640-B0BF-4E7F-8559-5D883C2A1C16

P5875

Q37109698-09B87369-FA66-4E77-8F85-7D91826A4A11

P698

Q37109698-3F89C5E8-36E7-4AA9-A57C-E119E7A8B038

P932

Q37109698-BAC79FBA-6F0E-4AAA-BD43-AC81580B7B62

P356

ONCOTARGET.7635

P1433

P1476

Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma

@en

P2093

Bojana J Simovic Markovic

http://www.w3.org/2001/XMLSchema#string

Milos Z Milosavljevic

http://www.w3.org/2001/XMLSchema#string

Miodrag L Lukic

http://www.w3.org/2001/XMLSchema#string

Nada N Pejnovic

http://www.w3.org/2001/XMLSchema#string

Slobodanka L J Mitrovic

http://www.w3.org/2001/XMLSchema#string

P2860

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

IL-33 reduces the development of atherosclerosis

IL-1 is required for tumor invasiveness and angiogenesis

IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.

Role of IL-33 and its receptor in T cell-mediated autoimmune diseases

Potential dual immunomodulatory role of VEGF in ulcerative colitis and colorectal carcinoma

Role of autophagy in cancer: management of metabolic stress.

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice.

P304

18106-18115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.7635

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Nebojsa Arsenijevic

Ivan P Jovanovic

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

296055102

http://www.w3.org/2001/XMLSchema#string

P698

26919112

http://www.w3.org/2001/XMLSchema#string

P932

4951275

http://www.w3.org/2001/XMLSchema#string